Surgeon preferences for self-treatment in locally advanced non–small cell lung cancer: Would we practice what we preach?

This survey reflects the current personal understanding of surgeons regarding multimodal treatment of potentially resectable lung cancer in the era of immunotherapy and targeted therapies. Although the work is not meant as a best practice document, it may represent valuable educational material for the multidisciplinary team and an information tool to aid the shared decision making process.